CorMedix CRMD Income Statement
| FY'25 | FY'23 | FY'22 | ||
|---|---|---|---|---|
| $163.06M— | -$46.34M-56.0% | -$29.7M-5.3% | ||
| $164.66M— | -$48.89M-60.1% | -$30.54M-4.0% | ||
| $150.14M— | -$48.96M-59.9% | -$30.62M-4.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is CorMedix's revenue?
- CorMedix (CRMD) generated $400.1M in revenue over the trailing twelve months, up 384.6% year over year.
- Is CorMedix profitable?
- CorMedix reported $181.0M in net income over the trailing twelve months, a 45.2% net margin.
- What are CorMedix's profit margins?
- Gross margin is 91.9% and operating margin is 48.4%, with a 45.2% net margin.
- What is CorMedix's earnings per share?
- CorMedix's diluted EPS over the trailing twelve months is $2.04.
- Where does CorMedix's income statement data come from?
- Every line is extracted from CorMedix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
